16 results
8-K
EX-99.1
CGTX
Cognition Therapeutics Inc
26 Mar 24
Cognition Therapeutics Reports Year End 2023 Financial Results and Provides Business Update
7:12am
and continue to innovate our existing products; our ability to defend our intellectual property; the impacts of ongoing global and regional conflicts
8-K
EX-99.1
CGTX
Cognition Therapeutics Inc
4 Jan 24
Other Events
4:21pm
compete; our ability to implement our strategic initiatives and continue to innovate our existing products; our ability to defend our intellectual
8-K
EX-99.1
CGTX
Cognition Therapeutics Inc
2 Nov 23
Cognition Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
7:41am
and continue to innovate our existing products; our ability to defend our intellectual property; the impact of the COVID-19 pandemic on our business
8-K
EX-99.1
CGTX
Cognition Therapeutics Inc
12 Sep 23
Other Events
7:00am
s a nd profitability; the evolution of the markets in which we compete; our ability to implement our strategic initiatives and continue to innovate
8-K
EX-99.1
CGTX
Cognition Therapeutics Inc
24 Aug 23
Regulation FD Disclosure
7:00am
ability to implement our strategic initiatives and continue to innovate our existing products; our ability to defend our intellectual property; the impact
8-K
EX-99.1
d6yp848471xb7u0qda
8 Aug 23
Cognition Therapeutics Reports Second Quarter 2023 Financial Results and Business Update
7:05am
8-K
EX-99.1
nx7s2b lqoyr00l80fh
28 Jun 23
Cognition Therapeutics Announces Positive Topline Results for CT1812 Phase 2 SEQUEL Study for Mild-to-Moderate Alzheimer’s Disease
7:27am
8-K
EX-99.2
ricpaxbxct6 2m60rq8
28 Jun 23
Cognition Therapeutics Announces Positive Topline Results for CT1812 Phase 2 SEQUEL Study for Mild-to-Moderate Alzheimer’s Disease
7:27am
8-K
EX-99.1
hns9yhgtciaz6bkf 2wx
4 May 23
Cognition Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
4:06pm
8-K
EX-99.1
c9yso 0nu88u
19 Apr 23
Developing disease-modifying medicines for degenerative disorders Analyst Breakfast April 2023
7:30am
8-K
EX-99.1
e4bgvn5vcu43dx
16 Nov 22
Developing disease - modifying medicines for degenerative disorders November 2022
5:18pm
8-K
EX-99.1
as4z1nv enepyfs
14 Nov 22
Cognition Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
8:00am
8-K
EX-99.1
o82alnl
29 Aug 22
Developing disease- modifying medicines for degenerative disorders August 2022
6:36am
8-K
EX-99.1
xerkih4salwdpkzad
9 Aug 22
Cognition Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
7:15am
8-K
EX-99.1
znv3t6s7
11 May 22
Cognition Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update
7:06am
8-K
EX-99.1
y4v22 rvuhz7lpoz
30 Mar 22
Cognition Therapeutics Reports Year End 2021 Financial Results and Provides
7:29am
- Prev
- 1
- Next